APO-AMOXI CLAV 250MG/62.5MG PER 5ML 250 MG / 5 ML
AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 250 MG / 5 ML CLAVULANIC ACID (POTASSIUM CLAVULANATE) : 62.5 MG / 5 ML · DIN 02243987 · APOTEX INC
Health Canada status: DORMANT
What is APO-AMOXI CLAV 250MG/62.5MG PER 5ML?
APO-AMOXI CLAV 250MG/62.5MG PER 5ML 250 MG / 5 ML contains AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 250 MG / 5 ML CLAVULANIC ACID (POTASSIUM CLAVULANATE) : 62.5 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02243987, held by APOTEX INC, supplied as POWDER FOR SUSPENSION for ORAL administration. Health Canada currently lists it as dormant, status dated 04-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is APO-AMOXI CLAV 250MG/62.5MG PER 5ML called?
The same molecule, AMOXICILLIN AND BETA-LACTAMASE INHIBITOR, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| AUGMENTIN | Latin | Bahrain, Czechia |
| Amoxil | Latin | Australia, Bahrain |
| APO-Amoxycillin | Latin | Australia |
| Amoxycillin Sandoz | Latin | Australia |
| Omacillin | Latin | Bahrain, Saudi Arabia |
| Amimox® | Latin | Sweden |
| Betaklav | Latin | Czechia, Sweden |
| KLAVOX | Latin | Bahrain |
| AMILOXYN | Latin | Australia |
| APX-Amoxicillin/Clavulanic Acid | Latin | Australia |
| Cilamox | Latin | Australia |
| COMOX | Latin | Australia |
| Curam | Latin | Australia, Bahrain |
| AMOXICILLIN-WGR | Latin | Australia |
| MOXICLAV | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02243987 |
|---|---|
| Brand name | APO-AMOXI CLAV 250MG/62.5MG PER 5ML |
| Generic / active ingredient | AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 250 MG / 5 ML CLAVULANIC ACID (POTASSIUM CLAVULANATE) : 62.5 MG / 5 ML |
| Manufacturer | APOTEX INC |
| Strength | 250 MG / 5 ML |
| Dosage form | POWDER FOR SUSPENSION |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01CR02 AMOXICILLIN AND BETA-LACTAMASE INHIBITOR |
| AHFS class | 08:12.16.08 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 04-Aug-2017 |
| Original market date | 2001-10-23 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02243987 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2243987 |
| Brand name | APO-AMOXI CLAV 250MG/62.5MG PER 5ML |
| Active ingredient / INN | AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 250 MG / 5 ML CLAVULANIC ACID (POTASSIUM CLAVULANATE) : 62.5 MG / 5 ML |
| ATC code | J01CR02 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01 |
| AHFS class | 08:12.16.08 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | APOTEX INC |
Which pack is which?
| Strength on the label | 250 MG / 5 ML |
|---|---|
| Dosage form | POWDER FOR SUSPENSION |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Is AMOXICILLIN AND BETA-LACTAMASE INHIBITOR in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code J01CR02 AMOXICILLIN AND BETA-LACTAMASE INHIBITOR. 28 of 59 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-AMOXI CLAV | 500 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02510634 |
| AG-AMOXI CLAV | 875 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02510642 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 100 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02495910 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 1000 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02495929 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 2000 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02495937 |
| AMOXICILLIN/CLAV | 500 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02536021 |
| AMOXICILLIN/CLAV | 875 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02536048 |
| APO-AMOXI CLAV | 125 MG | TABLET | APOTEX INC | MARKETED | DIN 02243350 |
| APO-AMOXI CLAV | 500 MG | TABLET | APOTEX INC | MARKETED | DIN 02243351 |
| APO-AMOXI CLAV | 875 MG | TABLET | APOTEX INC | MARKETED | DIN 02245623 |
Who else supplies AMOXICILLIN AND BETA-LACTAMASE INHIBITOR worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. AMOXICILLIN AND BETA-LACTAMASE INHIBITOR appears in 3391 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does AMOXICILLIN AND BETA-LACTAMASE INHIBITOR cost around the world?
AMOXICILLIN AND BETA-LACTAMASE INHIBITOR is listed on 15 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 153 | 166 | SAR███.██ |
| Australia | ex-manufacturer | 34 | 132 | AUD███.██ |
| South Africa | single exit price | 96 | 122 | ZAR███.██ |
| United States | acquisition | 10 | 98 | USD███.██ |
| Bahrain | retail (max) | 36 | 93 | BHD███.██ |
| Czechia | max producer price (ex-factory) | 15 | 41 | CZK███.██ |
| Romania | max producer price | 25 | 41 | RON███.██ |
| Sweden | AIP (pharmacy purchase price) | 14 | 38 | SEK███.██ |
| Austria | KVP (Kassenverkaufspreis) | 18 | 32 | EUR███.██ |
| United Kingdom | hospital | 15 | 15 | GBP███.██ |
| Luxembourg | reimbursement | 9 | 9 | EUR███.██ |
| Iceland | max wholesale | 3 | 5 | ISK███.██ |
| Greece | producer price (ex-factory) | 4 | 4 | EUR███.██ |
| Hungary | producer price (ex-factory) | 3 | 3 | HUF███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
800 pack listings across 436 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every AMOXICILLIN AND BETA-LACTAMASE INHIBITOR pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.